{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:22:58Z","timestamp":1777443778119,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"crossref","award":["BI-FR\/08-10-003"],"award-info":[{"award-number":["BI-FR\/08-10-003"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"crossref","award":["1000-07-310183"],"award-info":[{"award-number":["1000-07-310183"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ejphar.2014.08.039","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T09:16:16Z","timestamp":1410254176000},"page":"81-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Chemo-sensitizing effects of EP4 receptor-induced inactivation of nuclear factor-\u03baB"],"prefix":"10.1016","volume":"742","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9476-601X","authenticated-orcid":false,"given":"Martina","family":"Gobec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matev\u017e","family":"Prijatelj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozo","family":"Deli\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tijana","family":"Markovi\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Mlinari\u010d-Ra\u0161\u010dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.08.039_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03256435","article-title":"Detection of KCNJ11 Gene Mutations in a family with neonatal diabetes mellitus implications for therapeutic management of family members with long-standing disease","volume":"16","author":"Abbasi","year":"2012","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.ejphar.2014.08.039_bib2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/sj.cdd.4401874","article-title":"Targeting NF-kappaB in hematologic malignancies","volume":"13","author":"Braun","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2014.08.039_bib3","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0006-2952(02)00931-0","article-title":"Basal levels and patterns of anticancer drug-induced activation of nuclear factor-\u03baB (NF-\u03baB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells","volume":"63","author":"Chuang","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.08.039_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1200\/JCO.1989.7.4.415","article-title":"Drug-resistance in multiple myeloma and non-Hodgkin\u2019s lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy","volume":"7","author":"Dalton","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2014.08.039_bib5","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1038\/sj.onc.1210187","article-title":"NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia","volume":"26","author":"Fabre","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2014.08.039_bib6","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1002\/j.1460-2075.1991.tb07837.x","article-title":"P53 Ii frequently mutated in burkitts-lymphoma cell-lines","volume":"10","author":"Farrell","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2014.08.039_bib7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00001622-199309000-00002","article-title":"Biologic and molecular characterization of non-Hodgkin\u2019s lymphoma","volume":"5","author":"Gaidano","year":"1993","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.ejphar.2014.08.039_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses","volume":"16","author":"Ghosh","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2014.08.039_bib9","doi-asserted-by":"crossref","first-page":"e41961","DOI":"10.1371\/journal.pone.0041961","article-title":"Selective cytotoxicity of amidinopiperidine based compounds towards burkitt\u2019s lymphoma cells involves proteasome inhibition","volume":"7","author":"Gobec","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2014.08.039_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1471-4906(01)02154-8","article-title":"Prostaglandins as modulators of immunity","volume":"23","author":"Harris","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejphar.2014.08.039_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappa B signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2014.08.039_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/mc.20217","article-title":"NF-kappaB and cancer: mechanisms and targets","volume":"45","author":"Karin","year":"2006","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ejphar.2014.08.039_bib13","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.4049\/jimmunol.165.4.1743","article-title":"The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes","volume":"165","author":"Khoshnan","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2014.08.039_bib14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.cdd.4401877","article-title":"NF-kappaB and IKK as therapeutic targets in cancer","volume":"13","author":"Kim","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2014.08.039_bib15","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1073\/pnas.90.12.5742","article-title":"p53 mutations increase resistance to ionizing radiation","volume":"90","author":"Lee","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2014.08.039_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4161\/cbt.7.1.5128","article-title":"Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin\u2019s lymphoma cells","volume":"7","author":"Li","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejphar.2014.08.039_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JCO.1991.9.1.17","article-title":"P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil","volume":"9","author":"Miller","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2014.08.039_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2217\/pgs.10.27","article-title":"Human lymphoblastoid cell line panels: novel tools for assessing shared drug pathways","volume":"11","author":"Morag","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ejphar.2014.08.039_bib19","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1084\/jem.20081163","article-title":"Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4","volume":"205","author":"Murn","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2014.08.039_bib20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejphar.2010.10.053","article-title":"Inactivation of nuclear factor-kappaB by citrus flavanone hesperidin contributes to apoptosis and chemo-sensitizing effect in Ramos cells","volume":"650","author":"Nazari","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.08.039_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1471-4914(02)02375-4","article-title":"NF-kappa B as a therapeutic target in cancer","volume":"8","author":"Orlowski","year":"2002","journal-title":"Trends in Mol. Med."},{"key":"10.1016\/j.ejphar.2014.08.039_bib22","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.2042-7158.2012.01499.x","article-title":"EP4 receptor signalling in immature B cells involves cAMP and NF-kappaB dependent pathways","volume":"64","author":"Prijatelj","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.08.039_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.prostaglandins.2011.04.001","article-title":"Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cells","volume":"95","author":"Prijatelj","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.ejphar.2014.08.039_bib25","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/jnr.22000","article-title":"Utility of lymphoblastoid cell lines","volume":"87","author":"Sie","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2014.08.039_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.leu.2403171","article-title":"NF-kappaB\/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors","volume":"18","author":"Turco","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.ejphar.2014.08.039_bib27","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/S1470-2045(11)70335-7","article-title":"Genetic heterogeneity and cancer drug resistance","volume":"13","author":"Turner","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejphar.2014.08.039_bib28","doi-asserted-by":"crossref","first-page":"a003350","DOI":"10.1101\/cshperspect.a003350","article-title":"Signaling to NF-kappaB: regulation by ubiquitination","volume":"2","author":"Wertz","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ejphar.2014.08.039_bib29","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood-2003-11-4039","article-title":"Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-kappaB survival pathway signaling","volume":"104","author":"Weston","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2014.08.039_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/095530097143374","article-title":"Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells","volume":"72","author":"Yamagishi","year":"1997","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.ejphar.2014.08.039_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11010-008-9838-x","article-title":"Docosahexaenoic acid sensitizes Ramos cells to Gamma-irradiation-induced apoptosis through involvement of PPAR-gamma activation and NF-kappaB suppression","volume":"317","author":"Zand","year":"2008","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.ejphar.2014.08.039_bib32","doi-asserted-by":"crossref","first-page":"10029","DOI":"10.1128\/JVI.02241-06","article-title":"Bortezomib induces apoptosis of Epstein\u2013Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells","volume":"81","author":"Zou","year":"2007","journal-title":"J. Virol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400644X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400644X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T16:25:44Z","timestamp":1565799944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991400644X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":31,"alternative-id":["S001429991400644X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.08.039","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemo-sensitizing effects of EP4 receptor-induced inactivation of nuclear factor-\u03baB","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}